WCBA
Weaver C. Barksdale & Associates’s Amgen AMGN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.84M | Sell |
6,577
-59
| -0.9% | -$16.5K | 1.76% | 27 |
|
|
2025
Q1 | $2.07M | Sell |
6,636
-154
| -2% | -$48K | 1.98% | 14 |
|
|
2024
Q4 | $1.77M | Sell |
6,790
-166
| -2% | -$43.3K | 1.69% | 29 |
|
|
2024
Q3 | $2.24M | Sell |
6,956
-259
| -4% | -$83.5K | 2.02% | 14 |
|
|
2024
Q2 | $2.25M | Sell |
7,215
-120
| -2% | -$37.5K | 2.14% | 9 |
|
|
2024
Q1 | $2.09M | Sell |
7,335
-45
| -0.6% | -$12.8K | 1.91% | 19 |
|
|
2023
Q4 | $2.13M | Sell |
7,380
-1,887
| -20% | -$543K | 2.08% | 13 |
|
|
2023
Q3 | $2.49M | Buy |
9,267
+1,531
| +20% | +$411K | 2.12% | 6 |
|
|
2023
Q2 | $1.72M | Sell |
7,736
-477
| -6% | -$106K | 1.7% | 33 |
|
|
2023
Q1 | $1.99M | Sell |
8,213
-398
| -5% | -$96.2K | 1.86% | 21 |
|
|
2022
Q4 | $2.26M | Sell |
8,611
-1,086
| -11% | -$285K | 1.99% | 15 |
|
|
2022
Q3 | $2.19M | Sell |
9,697
-613
| -6% | -$138K | 2.19% | 2 |
|
|
2022
Q2 | $2.51M | Buy |
10,310
+742
| +8% | +$180K | 2.33% | 1 |
|
|
2022
Q1 | $2.31M | Buy |
9,568
+127
| +1% | +$30.7K | 2.06% | 5 |
|
|
2021
Q4 | $2.12M | Buy |
+9,441
| New | +$2.12M | 1.92% | 18 |
|
|
2017
Q4 | $1.49M | Sell |
8,589
-86
| -1% | -$15K | 1.57% | 30 |
|
|
2017
Q3 | $1.62M | Buy |
8,675
+99
| +1% | +$18.5K | 1.8% | 9 |
|
|
2017
Q2 | $1.48M | Hold |
8,576
| – | – | 1.72% | 13 |
|
|
2017
Q1 | $1.41M | Buy |
8,576
+1,798
| +27% | +$295K | 1.66% | 27 |
|
|
2016
Q4 | $991K | Buy |
6,778
+1,068
| +19% | +$156K | 1.6% | 17 |
|
|
2016
Q3 | $952K | Buy |
5,710
+510
| +10% | +$85K | 1.6% | 20 |
|
|
2016
Q2 | $791K | Hold |
5,200
| – | – | 1.37% | 43 |
|
|
2016
Q1 | $780K | Sell |
5,200
-33
| -0.6% | -$4.95K | 0.59% | 68 |
|
|
2015
Q4 | $849K | Buy |
+5,233
| New | +$849K | 0.66% | 49 |
|